Question 1

What is the catalog number for Gene Mutation Detection Kit for Moderately to well differentiated adenocarcinoma (E(L858R); K(-) Mutation)?

Accepted Answer

The catalog number for Gene Mutation Detection Kit for Moderately to well differentiated adenocarcinoma (E(L858R); K(-) Mutation) is MLEL858-189.

Question 2

What sizes are available for Gene Mutation Detection Kit for Moderately to well differentiated adenocarcinoma (E(L858R); K(-) Mutation)?

Accepted Answer

Gene Mutation Detection Kit for Moderately to well differentiated adenocarcinoma (E(L858R); K(-) Mutation) is available in the following size(s): 1 Kit.

Question 3

Is Gene Mutation Detection Kit for Moderately to well differentiated adenocarcinoma (E(L858R); K(-) Mutation) in stock?

Accepted Answer

Gene Mutation Detection Kit for Moderately to well differentiated adenocarcinoma (E(L858R); K(-) Mutation) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 5

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 6

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Gene Mutation Detection Kit for Moderately to well differentiated adenocarcinoma (E(L858R); K(-) Mutation)

Product Specifications

Frequently Asked Questions

Explore Other Products

CD5 (C5/473 + CD5/54/F6), CF594 conjugate, 0.1mg/mL

Hepatocyte Specific Antigen (HSA133), CF568 conjugate, 0.1mg/mL

CD20 / MS4A1 (B-Cell Marker) (MS4A1/3410), CF647 conjugate, 0.1mg/mL

Pgp9.5 (UCHL-1) (13C4), 0.2mg/mL

Glypican-3 (GPC3) (Hepatocellular Carcinoma Marker) (rGPC3/863), 1mg/mL

MMP9 (Matrix Metalloproteinase 9) (MMP9/2477), CF405S conjugate, 0.1mg/mL